{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:37:21Z","timestamp":1787686641997,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.maturitas.2019.03.011","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T18:36:05Z","timestamp":1553020565000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Management of dyslipidaemias in the elderly population\u2014A narrative review"],"prefix":"10.1016","volume":"124","author":[{"given":"Panagiotis","family":"Anagnostis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Vaitsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Veneti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.maturitas.2019.03.011_bib0005","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.maturitas.2019.03.011_bib0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4158\/EP171764.GL","article-title":"American association of clinical endocrinologists and american college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease - executive summary","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.maturitas.2019.03.011_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.0015","article-title":"Management of blood cholesterol","author":"Alenghat","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.maturitas.2019.03.011_bib0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cen.13085","article-title":"Effects of gender, age and menopausal status on serum apolipoprotein concentrations","volume":"85","author":"Anagnostis","year":"2016","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"10.1016\/j.maturitas.2019.03.011_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.maturitas.2015.02.262","article-title":"Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions","volume":"81","author":"Anagnostis","year":"2015","journal-title":"Maturitas"},{"issue":"8","key":"10.1016\/j.maturitas.2019.03.011_bib0030","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-152-8-201004200-00005","article-title":"Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial","volume":"152","author":"Glynn","year":"2010","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.maturitas.2019.03.011_bib0035","first-page":"1093","article-title":"Investigators, cardiovascular risk estimation in older persons: SCORE O.P, Eur","volume":"23","author":"Cooney","year":"2016","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"issue":"3","key":"10.1016\/j.maturitas.2019.03.011_bib0040","first-page":"154","article-title":"Cholesterol and cardiovascular disease in the elderly. Facts and gaps","volume":"4","author":"Felix-Redondo","year":"2013","journal-title":"Aging Dis."},{"key":"10.1016\/j.maturitas.2019.03.011_bib0045","first-page":"1","article-title":"Total and high-density lipoprotein cholesterol in adults: United States, 2015-2016","volume":"290","author":"Carroll","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"12","key":"10.1016\/j.maturitas.2019.03.011_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008464","article-title":"The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13)","volume":"4","author":"van Hateren","year":"2009","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.maturitas.2019.03.011_bib0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-115-9-687","article-title":"Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study","volume":"115","author":"Wong","year":"1991","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.maturitas.2019.03.011_bib0060","article-title":"Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review","volume":"6","author":"Ravnskov","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.maturitas.2019.03.011_bib0065","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/00325481.2016.1243005","article-title":"Hypertriglyceridemia: the importance of identifying patients at risk","volume":"128","author":"Kushner","year":"2016","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.maturitas.2019.03.011_bib0070","first-page":"198","article-title":"Trends in elevated triglyceride in adults: United States, 2001-2012","volume":"198","author":"Carroll","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"20","key":"10.1016\/j.maturitas.2019.03.011_bib0075","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.maturitas.2019.03.011_bib0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.maturitas.2019.03.011_bib0085","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jacc.2007.10.038","article-title":"Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial","volume":"51","author":"Miller","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.maturitas.2019.03.011_bib0090","first-page":"1","article-title":"Prevalence of low high-density lipoprotein cholesterol among adults, by physical activity: united States, 2011-2014","volume":"276","author":"Zwald","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"13","key":"10.1016\/j.maturitas.2019.03.011_bib0095","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9602","key":"10.1016\/j.maturitas.2019.03.011_bib0100","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2019.03.011_bib0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2017.11.011","article-title":"Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit?","volume":"108","author":"Anagnostis","year":"2018","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.maturitas.2019.03.011_bib0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/0003319714532169","article-title":"Health benefits of the Mediterranean Diet: an update of research over the last 5 years","volume":"66","author":"Gotsis","year":"2015","journal-title":"Angiology"},{"issue":"8","key":"10.1016\/j.maturitas.2019.03.011_bib0115","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archinte.165.8.929","article-title":"Mediterranean diet and survival among patients with coronary heart disease in Greece","volume":"165","author":"Trichopoulou","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"8","key":"10.1016\/j.maturitas.2019.03.011_bib0120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1017\/S0007114518002179","article-title":"Mediterranean diet and mortality in the elderly: a prospective cohort study and a meta-analysis","volume":"120","author":"Bonaccio","year":"2018","journal-title":"Br. J. Nutr."},{"issue":"25","key":"10.1016\/j.maturitas.2019.03.011_bib0125","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.maturitas.2019.03.011_bib0130","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5708","article-title":"Assessment of risk factors and biomarkers associated with risk of cardiovascular disease among women consuming a mediterranean diet","volume":"1","author":"Ahmad","year":"2018","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.maturitas.2019.03.011_bib0135","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study","volume":"99","author":"de Lorgeril","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2019.03.011_bib0140","doi-asserted-by":"crossref","first-page":"k3359","DOI":"10.1136\/bmj.k3359","article-title":"Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study","volume":"362","author":"Ramos","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.maturitas.2019.03.011_bib0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4140\/TCP.n.2015.20","article-title":"Statins for the primary prevention of cardiovascular disease in the elderly","volume":"30","author":"Lowe","year":"2015","journal-title":"Consult. Pharm. : J. Am. Soc. Consult. Pharm."},{"issue":"18","key":"10.1016\/j.maturitas.2019.03.011_bib0150","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2165\/11638240-000000000-00000","article-title":"Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis","volume":"72","author":"de Vries","year":"2012","journal-title":"Drugs"},{"issue":"21","key":"10.1016\/j.maturitas.2019.03.011_bib0155","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-Reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.maturitas.2019.03.011_bib0160","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s40266-015-0290-9","article-title":"Statins for primary prevention of cardiovascular disease in elderly patients: systematic review and meta-analysis","volume":"32","author":"Teng","year":"2015","journal-title":"Drugs Aging"},{"issue":"21","key":"10.1016\/j.maturitas.2019.03.011_bib0165","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in Intermediate-Risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2019.03.011_bib0170","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5114\/aoms.2013.35424","article-title":"Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study","volume":"9","author":"Athyros","year":"2013","journal-title":"Arch. Med. Sci."},{"issue":"9326","key":"10.1016\/j.maturitas.2019.03.011_bib0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"issue":"9346","key":"10.1016\/j.maturitas.2019.03.011_bib0180","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.maturitas.2019.03.011_bib0185","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1161\/01.CIR.96.12.4211","article-title":"Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)","volume":"96","author":"Miettinen","year":"1997","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.maturitas.2019.03.011_bib0190","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/0003-4819-129-9-199811010-00002","article-title":"Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial","volume":"129","author":"Lewis","year":"1998","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.maturitas.2019.03.011_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-147-1-200707030-00002","article-title":"Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease","volume":"147","author":"Wenger","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.maturitas.2019.03.011_bib0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamacardio.2016.4052","article-title":"Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease","volume":"2","author":"Rodriguez","year":"2017","journal-title":"JAMA Cardiol."},{"issue":"10170","key":"10.1016\/j.maturitas.2019.03.011_bib0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","author":"Armitage","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.maturitas.2019.03.011_bib0210","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008546","article-title":"Statin use and adverse effects among adults &75 years of age: insights from the patient and provider assessment of lipid management (PALM) registry","volume":"7","author":"Nanna","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.maturitas.2019.03.011_bib0215","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/2040622316672544","article-title":"Ezetimibe: an update on its clinical usefulness in specific patient groups","volume":"8","author":"Hammersley","year":"2017","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"25","key":"10.1016\/j.maturitas.2019.03.011_bib0220","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.maturitas.2019.03.011_bib0225","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.2174\/1381612811319170020","article-title":"The role of fibrate treatment in dyslipidemia: an overview","volume":"19","author":"Katsiki","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.maturitas.2019.03.011_bib0230","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group","volume":"341","author":"Rubins","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.maturitas.2019.03.011_bib0235","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamacardio.2016.4828","article-title":"Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes","volume":"2","author":"Elam","year":"2017","journal-title":"JAMA Cardiol."},{"issue":"12","key":"10.1016\/j.maturitas.2019.03.011_bib0240","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/ijcp.12903","article-title":"Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options","volume":"70","author":"Anagnostis","year":"2016","journal-title":"Int. J. Clin. Pract."},{"issue":"2","key":"10.1016\/j.maturitas.2019.03.011_bib0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1074248413514481","article-title":"The therapeutic role of niacin in dyslipidemia management","volume":"19","author":"Boden","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"24","key":"10.1016\/j.maturitas.2019.03.011_bib0250","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.maturitas.2019.03.011_bib0255","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/eht055","article-title":"HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin\/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment","volume":"34","author":"Group","year":"2013","journal-title":"Eur. Heart J."},{"issue":"9177","key":"10.1016\/j.maturitas.2019.03.011_bib0260","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial","volume":"354","year":"1999","journal-title":"Lancet"},{"issue":"9567","key":"10.1016\/j.maturitas.2019.03.011_bib0265","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2019.03.011_bib0270","article-title":"Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease","volume":"7","author":"Abdelhamid","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.maturitas.2019.03.011_bib0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Omega-3 treatment trialists, associations of Omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77917 individuals","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"1","key":"10.1016\/j.maturitas.2019.03.011_bib0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine n-3 fatty acids and prevention of cardiovascular disease and Cancer","volume":"380","author":"Manson","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.maturitas.2019.03.011_bib0285","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.maturitas.2019.03.011_bib0290","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1804989","article-title":"Effects of n-3 fatty acid supplements in diabetes mellitus","volume":"379","author":"Group","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.maturitas.2019.03.011_bib0295","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.maturitas.2019.03.011_bib0300","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512219301355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512219301355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:14:51Z","timestamp":1759914891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512219301355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":60,"alternative-id":["S0378512219301355"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2019.03.011","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of dyslipidaemias in the elderly population\u2014A narrative review","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2019.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}